Filing Details
- Accession Number:
- 0001628280-25-029631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-05 16:04:33
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-05
- Accepted Time:
- 2025-06-05 16:04:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1995298 | A. Sheila Denton | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Counsel | No | Yes | No | No |
Transaction Summary
| Sold: | 1,795 shares | Avg. Price: $68.00 | Total Value: $122,060.00 |
| Number of Shares After Transactions: | 26,504 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-03 | 1,795 | $58.06 | 28,299 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-03 | 1,795 | $68.00 | 26,504 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2025-06-03 | 1,795 | $0.00 | 1,795 | $58.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,757 | 2033-10-02 | No | 4 | M | Direct |
Footnotes
- This includes an aggregate of 25,848 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
- Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.
Billionaire Hedge Funds
